All Type 2 diabetes articles
-
Formulary decision guideTrajenta® (linagliptin) 5 mg film-coated tablets
Information intended for healthcare professionals only. This promotional formulary decision guide was initiated, funded, and reviewed by Boehringer Ingelheim Limited and Lilly Diabetes Alliance. The format was developed by Guidelines in Practice . View prescribing information Key points on this medicine Linagliptin: ...
-
On demand webinars
Exploring a Cardiovascular approach to patients with Type 2 Diabetes with a focus on current guidance
This webinar has been commissioned by Boehringer Ingelheim Limited and Lilly Diabetes Alliance and organised in partnership with Guidelines in Practice . See below for full disclaimer. Prescribing information for Jardiance (empagliflozin) can be viewed online: www.jardiancepi.co.uk Video: Exploring a Cardiovascular approach to patients ...
-
Test and reflect
Patient scenarios: diabetes and cardiovascular risk
The following scenarios are fictitious but similar to those experienced by real patients and are designed to help you reflect on what you have learnt after reading the article. They could also be used for group discussion in an education or practice meeting. There are no right or wrong answers ...
-
Sponsored algorithm
Dipeptidyl peptidase-4 inhibitors: the different dosing requirements of adult patients with type 2 diabetes and comorbidities
This management algorithm has been commissioned and funded by Boehringer Ingelheim Limited and Lilly Diabetes Alliance.
-
On demand webinars
Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)
This promotional educational webinar has been organised and funded by Takeda UK Ltd. See bottom of page for full disclaimer. View prescribing information Video: DPP-4 inhibitors webinar Click here to complete the feedback and receive your CPD certificate ...
-
Supplement
Guideline for the managed introduction of biosimilar basal insulin
Guidelines identified a need for clinical guidance in a specific area and approached Mylan for an educational grant to support the development of a working party guideline. This working party guideline was developed by Guidelines , and the Chair and members of the group were chosen by and convened ...
-
Test and reflect
Collaborative stakeholder initiative for the management of type 2 diabetes in older people
This CPD activity consists of 3 multiple-choice questions (MCQs) designed to test your knowledge on the management of diabetes in older people, including in the context of frailty.
-
Formulary decision guide
Formulary decision guide: Ozempic®▼ (semaglutide)
Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Novo Nordisk in a format developed by Guidelines in Practice . It has been reviewed by Novo Nordisk, who commissioned the development of the formulary decision guide. Download the formulary decision guide ...
-
Digital edition
May 2019 issue
The digital edition of the May 2019 issue of Guidelines in Practice , featuring articles on: type 2 diabetes, fetal alcohol spectrum disorder, sexually transmitted infections, and GP appraisal tips.
-
Implementing guidelines
Type 2 diabetes: targets and treatments should be person-centred
Dr Clare Hambling and Dr Patrick Holmes highlight the key recommendations from the joint ADA/EASD consensus report on the management of hyperglycaemia in type 2 diabetes
-
Animation
Management of hyperglycaemia in type 2 diabetes, 2018: ADA/EASD consensus report
Watch this short animation, commissioned by Napp Pharmaceuticals Limited, to find out about the third joint consensus report on the management of hyperglycaemia in type 2 diabetes by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
-
Digital edition
February 2019 issue
The digital edition of the February 2019 issue of Guidelines in Practice , featuring articles on: COPD, covert medication, type 2 diabetes, and talking about weight with patients.
-
Pharmacist focus
Type 2 diabetes: the role of the practice pharmacist
Muhammad Siddiqur Rahman highlights the integral role of practice-based pharmacists in managing type 2 diabetes
-
Formulary decision guide
Semglee® ▼ (insulin glargine biosimilar)
This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice .
-
Test and reflect
Best practice in managing co-morbidities in type 2 diabetes
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on managing the co-morbidities of type 2 diabetes—you will then be prompted to reflect on your learning.
-
Co-morbidities in ...
Co-morbidities in type 2 diabetes
Dr Kevin Fernando describes eight common co-morbidities in patients with type 2 diabetes and how the co-existing conditions should be managed
-
Test and reflect
SIGN guideline on pharmacological management of type 2 diabetes
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on SIGN guideline recommendations on managing type 2 diabetes—you will then be prompted to reflect on your learning.
-
Implementing guidelines
Type 2 diabetes: what are the benefits and risks of glucose-lowering agents?
Dr Kevin Fernando explains how SIGN 154 offers evidence-based guidance on glucose control therapies for people with type 2 diabetes
-
News
SIGN updates diabetes guidance
The Scottish Intercollegiate Guidelines Network has updated its guidance on the management of diabetes and published new guidance on pharmacological management of glycaemic control in people with type 2 diabetes.
-
Test and reflect
NICE guideline on type 2 diabetes
This CPD activity consists of 4 multiple-choice questions (MCQs) designed to test your knowledge on type 2 diabetes in adults—you will then be prompted to reflect on your learning.
